An Antiviral Role for TRIM14 in Ebola Virus Infection

J Infect Dis. 2023 Nov 15;228(Suppl 7):S514-S521. doi: 10.1093/infdis/jiad325.

Abstract

Ebola virus (EBOV) is a highly pathogenic virus that encodes 7 multifunctional structural proteins. Multiple host factors have been reported to interact with the EBOV proteins. Here, we found that tripartite motif-containing 14 (TRIM14), an interferon-stimulated gene that mediates cellular signaling pathways associated with type I interferon and inflammatory cytokine production, interacts with EBOV nucleoprotein to enhance interferon-β (IFN-β) and nuclear factor-κB (NF-κB) promotor activation. Moreover, TRIM14 overexpression reduced viral replication in an infectious but biologically contained EBOVΔVP30 system by approximately 10-fold without affecting viral protein expression. Furthermore, TRM14-deficient mice were more susceptible to mouse-adapted EBOV infection than wild-type mice. Our data suggest that TRIM14 is a host factor with anti-EBOV activity that limits EBOV pathogenesis.

Keywords: Ebola virus; NF-κB; TRIM14; interferon.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Ebolavirus* / genetics
  • Hemorrhagic Fever, Ebola*
  • Interferon Type I / metabolism
  • Mice
  • Viral Proteins / metabolism

Substances

  • Interferon Type I
  • Viral Proteins
  • Trim14 protein, mouse